• Considerations for the use of herpes zoster vaccines Cite CITE Title : Considerations for the use of herpes zoster vaccines Personal Author(s) : Dooling, Kathleen L. Corporate Authors(s) : National Center for Immunization and Respiratory Diseases (U.S.). Division of Viral Diseases. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA) Published Date : 7/17/2017 Series : ACIP meeting Herpes Zoster Vaccine URL : https://stacks.cdc.gov/view/cdc/58920 Dooling, Kathleen L. (2017). Considerations for the use of herpes zoster vaccines. 201702(010306). Dooling, Kathleen L. "Considerations for the use of herpes zoster vaccines" 201702, no. 010306 (2017) Dooling, Kathleen L. "Considerations for the use of herpes zoster vaccines" vol. 201702, no. 010306, 2017 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 1.62 MB] Personal Author: Dooling, Kathleen L. 7/17/2017 | ACIP meeting Herpes Zoster Vaccine Description: Presentations June 2017 Day 1Publication date from document properties.zoster-05-dooling.pdf File Type: [PDF - 1.62 MB] File Type: [PDF - 1.62 MB] Immunogenicity and safety of Shingrix in adults previously vaccinated with a live-attenuated herpes zoster vaccine (zoster-048 study) Cite CITE Title : Immunogenicity and safety of Shingrix in adults previously vaccinated with a live-attenuated herpes zoster vaccine (zoster-048 study) Personal Author(s) : Colindres, Romulo Corporate Authors(s) : GlaxoSmithKline. Conference Author(s) : United States. Advisory Committee on Immunization Practices. Meeting (2017 June 21-22 : Atlanta, GA) Published Date : 7/14/2017 Series : ACIP meeting Herpes Zoster Vaccine URL : https://stacks.cdc.gov/view/cdc/58918 Colindres, Romulo (2017). Immunogenicity and safety of Shingrix in adults previously vaccinated with a live-attenuated herpes zoster vaccine (zoster-048 study). 201702(010304). Colindres, Romulo "Immunogenicity and safety of Shingrix in adults previously vaccinated with a live-attenuated herpes zoster vaccine (zoster-048 study)" 201702, no. 010304 (2017) Colindres, Romulo "Immunogenicity and safety of Shingrix in adults previously vaccinated with a live-attenuated herpes zoster vaccine (zoster-048 study)" vol. 201702, no. 010304, 2017 Export RIS Citation Information. Copy Copied Save Generic APA MLA Chicago RIS [PDF - 282.22 KB] Personal Author: Colindres, Romulo 7/14/2017 | ACIP meeting Herpes Zoster Vaccine Description: Presentations June 2017 Day 1Agenda lists presentation as: Herpes Zoster vaccine revaccination dataPublication date from document properties.zoster-03... File Type: [PDF - 282.22 KB] File Type: [PDF - 282.22 KB]

More +